Riker's Tambocor (flecainide)
Executive Summary
According to FDA minutes of its Cardio-Renal Drugs Advisory Cmte. meeting in June, the cmte. recommended approval of Tambocor for use in "symptomatic ventricular arrhythmias" rather than "symptomatic sustained ventricular tachycardia" as reported ("The Pink Sheet" June 25, p. 12).